longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Bluebird Bio

BLUE

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q1 FY2025 Earnings

Financial report interval: 2024.12.31 - 2025.03.31

Overview: Bluebird Bio(BLUE) the Revenue is 38.71 M (+108.4%);the EBIT is -21.51 M (+72.67%);the EPS is -2.98 (+58.77%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.04B108.43%
----
----
EBIT
-0.02B72.67%
----
----
EPS
-2.981158.77%
----
----

Revenue

ActualEstimateUnit: USD
qf

EBIT

ActualEstimateUnit: USD
qf

Net income

ActualEstimateUnit: USD
qf

EPS

ActualEstimateUnit: USD
qf